Skip to main content
SpringerLink
Log in
Book cover

Inflammatory Disorders of the Nervous System pp 175–186Cite as

Autoimmune Encephalitis: Clinical Features, Pathophysiology, and Treatment

  • Chapter
  • First Online:

  • 1403 Accesses

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Over the past two decades, the discovery of various antibodies related to autoimmune encephalitis has given us a new insight into pathogenic mechanisms and treatment of these syndromes. That is important since many patients with autoimmune encephalopathy are children and young adults. These patients often respond favorably to immunotherapy. Delay in diagnosis and treatment has been associated with a worse prognosis. In this chapter, we review the epidemiology, pathophysiology, clinical characteristics, diagnosis, and treatment of different syndromes associated with autoimmune encephalitis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77:179–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261–71.

    Article  PubMed  Google Scholar 

  3. Greenfield JG. Subacute spino-cerebellar degeneration occurring in elderly patients. Brain. 1934;57:161–76.

    Article  Google Scholar 

  4. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry. 1948;11:73–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Henson RA, Russell DS, Wilkinson M. Carcinomatous neuropathy and myopathy a clinical and pathological study. Brain. 1954;77:82–121.

    Article  CAS  PubMed  Google Scholar 

  6. Charatan FB, Brierley JB. Mental disorder associated with primary lung carcinoma. Br Med J. 1956;1:765–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Corsellis JA, Goldberg GJ, Norton AR. ‘Limbic encephalitis’ and its association with carcinoma. Brain. 1968;91:481–96.

    Article  CAS  PubMed  Google Scholar 

  8. Buckley C et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73–8.

    Article  CAS  PubMed  Google Scholar 

  9. Ances BM et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764–77.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dalmau J et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Dalmau J et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007;8:413–26.

    Article  CAS  PubMed  Google Scholar 

  13. Gable MS et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54:899–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gozzard P et al. Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study. Neurology. 2015;85:235–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76:795–800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Graus F et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48.

    Article  CAS  PubMed  Google Scholar 

  19. Sillevis Smitt P et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol. 2002;249:745–53.

    Article  PubMed  Google Scholar 

  20. Gultekin SH et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7):1481–94.

    Article  PubMed  Google Scholar 

  21. Honnorat J et al. Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer. Neurology. 2013;80:2226–32.

    Article  CAS  PubMed  Google Scholar 

  22. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore). 1992;71:59–72.

    Article  CAS  Google Scholar 

  23. Shams’ili S et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126:1409–18.

    Article  PubMed  Google Scholar 

  24. Saiz A et al. Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry. 2009;80:404–7.

    Article  CAS  PubMed  Google Scholar 

  25. Luque FA et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol. 1991;29:241–51.

    Article  CAS  PubMed  Google Scholar 

  26. Kim H, Lim Y, Kim K-K. Anti-ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI. J Clin Neurol. 2009;5:151–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Greenlee JE et al. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Ann Neurol. 1999;45:805–9.

    Article  CAS  PubMed  Google Scholar 

  28. Voltz R et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med. 1999;340:1788–95.

    Article  CAS  PubMed  Google Scholar 

  29. Dalmau J et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831–44.

    Article  PubMed  Google Scholar 

  30. Waragai M et al. Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy. J Neurol Neurosurg Psychiatry. 2006;77:111–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Saiz A et al. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry. 1999;66:214–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Antoine JC et al. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol. 1999;56:172–7.

    Article  CAS  PubMed  Google Scholar 

  33. David C, McPherson PS, Mundigl O, de Camilli P. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc Natl Acad Sci U S A. 1996;93:331–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Yu Z et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49:146–54.

    Article  CAS  PubMed  Google Scholar 

  35. Vernino S et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002;51:625–30.

    Article  PubMed  Google Scholar 

  36. Knudsen A et al. Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clin Exp Immunol. 2007;149:16–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tüzün E, Rossi JE, Karner SF, Centurion AF, Dalmau J. Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J Neuroimmunol. 2007;186:177–80.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Sabater L, Gómez-Choco M, Saiz A, Graus F. BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis. J Neuroimmunol. 2005;170:186–90.

    Article  CAS  PubMed  Google Scholar 

  39. Titulaer MJ et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70:1133–9.

    Article  PubMed  Google Scholar 

  41. Hacohen Y et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry. 2013;84:748–55.

    Article  PubMed  Google Scholar 

  42. Iizuka T et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504–11.

    Article  CAS  PubMed  Google Scholar 

  43. Shimazaki H, Ando Y, Nakano I, Dalmau J. Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry. 2007;78:324–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Pillay N, Gilbert JJ, Ebers GC, Brown JD. Internuclear ophthalmoplegia and ‘optic neuritis’: paraneoplastic effects of bronchial carcinoma. Neurology. 1984;34:788–91.

    Article  CAS  PubMed  Google Scholar 

  45. Lebas A, Husson B, Didelot A, Honnorat J, Tardieu M. Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol. 2010;25:742–5.

    Article  PubMed  Google Scholar 

  46. Wingfield T et al. Autoimmune encephalitis: a case series and comprehensive review of the literature. QJM. 2011;104:921–31.

    Article  CAS  PubMed  Google Scholar 

  47. Andrade DM, Tai P, Dalmau J, Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology. 2011;76:1355–7.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Irani SR et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69:892–900.

    Article  PubMed  Google Scholar 

  49. Sen A et al. Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies. Lancet (London/England). 2014;383:2018.

    Article  Google Scholar 

  50. Tofaris GK et al. Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology. 2012;79:195–6.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Fukata Y et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A. 2010;107:3799–804.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Lai M et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Höftberger R et al. Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology. 2015;84:2403–12.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Klein CJ et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013;70:229–34.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Irani SR et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72:241–55.

    Article  PubMed  Google Scholar 

  56. Petit-Pedrol M et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13:276–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Höftberger R et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81:1500–6.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Sabater L et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Suleiman J et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology. 2011;76:1252–5.

    Article  CAS  PubMed  Google Scholar 

  60. Cornelius JR et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011;68:733–8.

    Article  PubMed  Google Scholar 

  61. Hutchinson M et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;71:1291–2.

    Article  CAS  PubMed  Google Scholar 

  62. Mas N et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 2011;82:1399–401.

    Article  PubMed  Google Scholar 

  63. Clerinx K et al. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology. 2011;76:303–4.

    Article  CAS  PubMed  Google Scholar 

  64. Boronat A et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73:120–8.

    Article  CAS  PubMed  Google Scholar 

  65. Tobin WO et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83:1797–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Prüss H et al. Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia. Neurology. 2014;83:1384–6.

    Article  PubMed  Google Scholar 

  67. Lancaster E et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77:1698–701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology. 2010;75:1480–2.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Graus F et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Flanagan EP et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010;85:881–97.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Geschwind MD et al. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 2008;65:1341–6.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Florance NR et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–8.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363–8.

    Article  PubMed  Google Scholar 

  74. Gresa-Arribas N et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Tennesse, Geisinger Health System, 100 North Academy Avenue, Danville, PA, 17822, USA

    Ramin Zand MD

Authors
  1. Ramin Zand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ramin Zand MD .

Editor information

Editors and Affiliations

  1. Department of Neurology, LSU Health Sciences Center, Shreveport, Louisiana, USA

    Alireza Minagar

  2. Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, Louisiana, USA

    J. Steven Alexander

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Zand, R. (2017). Autoimmune Encephalitis: Clinical Features, Pathophysiology, and Treatment. In: Minagar, A., Alexander, J. (eds) Inflammatory Disorders of the Nervous System. Current Clinical Neurology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-51220-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51220-4_8

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-51218-1

  • Online ISBN: 978-3-319-51220-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation